Alt Atlas Ltd.
London
About Alt Atlas Ltd.
Alt Atlas is developing an AI-digital manufacturing platform linked to cell lines and smart tools allowing to reach production states faster and in a cost-effective way. Platform technology. B2B. Phase I: Cultivated meat. Phase II: Biotech (in-vitro toxicology testing, disease modeling). After almost a decade and billions invested, cultivated meat is still not in the market. According to GFI and New Harvest (main NPOs), AI is an underused tool in the field and is set to solve the complex multi-variable multi-factor scale-up challenge. In addition to that, the lack of relevant cell lines (cultivated meat starter material) is lacking and that is preventing innovation in the field. Product: Novel cell lines (non-GMO, multiple animal species) and how to use them (customized AI-based services). Alt Atlas is a technology enabler. Customers: cultivated meat B2C companies (producing the meat). The team has over 70 years of relevant combined experience at top universities, multinational food and agritech corporations and in building a StartUp in the field. The team members have: developed bioinformatic software platforms and tools, established state-of the art stem cell lines to improve human health and pioneered the cultivated meat ecosystem in Latin America.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $255.0K
- Funding stage: Seed
- Last round: Pre-Seed (May 2022)
- Website: alt-atlas.com
- Phone: [email protected]
Industries & Categories
Alternative Protein, Artificial Intelligence (AI), B2B, Biotechnology, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/alt-atlas-ltd-134963 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.